NeuroPace, Inc. (NPCE) vs Senseonics Holdings, Inc. (SENS)
NeuroPace, Inc. and Senseonics Holdings, Inc. are both Medical Devices companies. Senseonics Holdings, Inc. is the larger, with a market value of $546.7M against $479.5M — 1.1× the size. Senseonics Holdings, Inc. grew revenue faster over the last twelve months: 90.6% against 21.7%. NeuroPace, Inc. has the higher net margin (−18.6% vs −225.3%) and the higher return on invested capital (−44.6% vs −2,152.1%). Across the 18 metrics below, NeuroPace, Inc. leads on 11 and Senseonics Holdings, Inc. on 7.
Valuation
Profitability
| Metric | NPCE | SENS | Medical Devices median |
|---|---|---|---|
| Gross margin | 78.38% | 54.87% | 56.01% |
| Operating margin | (13.33%) | (223.22%) | (15.03%) |
| Net margin | (18.58%) | (225.34%) | (20.40%) |
| Free cash flow margin | (11.29%) | (199.47%) | (7.24%) |
| Return on equity | (122.05%) | (118.24%) | (15.32%) |
| Return on assets | (18.82%) | (66.88%) | (19.72%) |
| Return on invested capital | (44.64%) | (2,152.05%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack